clinical trial · NCT06647810
A Study in Healthy People to Test How 2 Different Formulations of BI 690517 Are Taken up in the Body and How Probenecid Influences the Amount of BI 690517 in the Blood
Boehringer Ingelheim·phase1·completed·n = 15
HealthyBI 690517 formulation 1BI 690517 formulation 2Probenecid
brief summary
This trial aims to test how two different formulations of BI 690517 are taken up by the body and how probenecid influences the amount of BI 690517 in the blood.
started
Nov 13, 2024
primary completion
Dec 12, 2024
completion
Jan 7, 2025
last updated
Jan 9, 2025
official title
Relative Bioavailability of Two Different BI 690517 Formulations as Well as the Effect of Multiple Doses of Probenecid on the Single Dose Pharmacokinetics of BI 690517 Following Oral Administration in Healthy Male and Female Subjects (a Randomised, Open-label, Three-way Crossover Trial)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol